Fort Baker Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Fort Baker Capital Management’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-201,147	Closed	-$2.08M	–	102
2023 Q2	$2.08M	Hold	201,147	–	–	0.28%	48
2023 Q1	$2.04M	Hold	201,147	–	–	0.42%	39
2022 Q4	$2M	Hold	201,147	–	–	0.61%	28
2022 Q3	$1.96M	Sell	201,147 -100,557	-33%	-$981K	0.29%	37
2022 Q2	$2.93M	Hold	301,704	–	–	0.46%	37
2022 Q1	$2.93M	Buy	301,704 +276,990	+1,121%	+$2.68M	0.45%	38
2021 Q4	$240K	Hold	24,714	–	–	0.04%	69
2021 Q3	$240K	Buy	+24,714	New	+$241K	0.06%	80

Other funds holding NKGN

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Fort Baker Capital Management's NKGN Position: Q3 2023 in Review

Fort Baker Capital Management sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q3 2023, closing a stake of 201,147 shares — an estimated $2.08M sold.

Fort Baker Capital Management first reported a position in NKGN in Q3 2021 and held it in 8 quarters. The position peaked at $2.93M in Q2 2022. 13 funds tracked by Wall St. Rank hold NKGN as of Q3 2023.

Fort Baker Capital Management reported no remaining NKGen Biotech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Fort Baker Capital Management sold 201,147 NKGen Biotech, Inc. Common Stock shares in Q3 2023, an estimated $2.08M.
Fort Baker Capital Management first reported a position in NKGen Biotech, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Fort Baker Capital Management's NKGen Biotech, Inc. Common Stock position peaked at $2.93M in Q2 2022.
13 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q3 2023.

Based on Fort Baker Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.